Clinical Trial

Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)

Study acronym: FOCUS / KOV-04
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Primary stage III-IV epithelial ovarian cancer randomizing between interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-04-12; most recent amendment 2026-02-11.
Status change: Not Yet Recruiting → Recruiting 2023-05-31
Trial Details
NCT Number NCT05827523
Lead Sponsor National Cancer Center, Korea
Conditions Ovarian Cancer
Enrollment 520 participants
Start Date 2023-05-31
Primary Completion 2027-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13